Migraine Report Migraine-Report | Page 12

Project Progress Report
Table – 1: Baseline Disease Characteristics of Ayurvedic Treatment Group
Sr. No CRF No. Age Sex
No. of
Conventional
Headache
Prophylaxis
Pre-ATP (Last 3
Treatment
Nausea Vomiting Photophobia Phonophobia Pre-ATP Pre-ATP
months)
Symptoms
History
(in years) Frequency
VAS MIDAS
Relieving Factor
1 001 28 F 14 > 4 times a month √ √ √ √ 8 20 90 YES Sleep, Pain Killer, Pregnancy
2 003 32 F 6 > 4 times a month √ √ √ √ 8 55 90 YES Painkiller
3 004 27 F 3 > 4 times a month √ √ √ √ 8 50 60 YES Sleep, Pain Killer
4 005 24 F 14 > 4 times a month х х √ √ 8 22 90 YES Sleep, Exhilaration, Painkiller
5 006 41 F 15 > 4 times a month √ √ √ √ 9 30 36 YES Sleep
6 008 38 F 11 > 4 times a month √ √ √ √ 7 22 30 YES Sleep
7 009 46 M 28 > 4 times a month х х √ √ 7 47 90 YES Sleep, Pain Killer, Exercise
8 010 36 F >20 years > 4 times a month √ √ √ √ 8 53 45 YES Sleep, Pain Killer
9 011 47 F 17 > 4 times a month √ √ √ √ 9 40 90 YES Sleep, Pain Killer
10 015 41 F 2 > 4 times a month √ √ √ √ 8 28 36 YES Sleep
11 016 51 M 6 2-4 times a month √ √ √ √ 9 28 60 YES Sleep, Pain Killer
12 024 50 F 7 > 4 times a month √ х √ √ 8 41 66 YES Sleep, Pain Killer
13 029 28 M 15 > 4 times a month √ √ √ √ 7 57 33 YES Sleep
14 031 42 F 5 > 4 times a month √ √ х √ 8 39 39 YES Sleep, Pain Killer
15 036 22 M 3 > 4 times a month √ х √ √ 8 27 43 YES Sleep
16 039 18 M 1 2-4 times a month √ х √ √ 7 41 36 YES Sleep
17 047 30 F 6 2-4 times a month √ √ √ √ 9 38 90 YES Sleep, Pain Killer
18 048 26 F 4 2-4 times a month х √ √ √ 9 48 39 YES Sleep, Exhilaration, Painkiller
19 050 27 M 1 2-4 times a month х √ х √ 8 35 30 YES Sleep, Pain Killer
20 053 40 F 15 > 4 times a month √ √ √ √ 9 52 65 YES Sleep, Pain Killer
21 055 30 F 1.5 2-4 times a month √ √ √ √ 9 47 60 YES Sleep, Pain Killer, Pregnancy
22 058 39 F 20 > 4 times a month √ √ √ √ 8 37 90 YES Sleep, Exhilaration, Painkiller
23 059 36 F 5 2-4 times a month √ х √ х 7 52 45 YES Sleep, Pain Killer
24 060 26 F 2 > 4 times a month √ √ х √ 9 39 36 YES Sleep, Pain Killer
Randomized controlled clinical trial to evaluate prophylactic
12 properties of Ayu rv ed ic Treatment Protocol in
refractory and chronic migraine patients